PharmaSource: The External Manufacturing Community Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES Biodeal Pharmaceuticals Raises Rs. 385 Crore ($44 Million) to Drive Global Expansion Read More » Transcenta to Sell Hangzhou CDMO Assets to WuXi Biologics Gland Pharma Secures Manufacturing Deal Covering 55 Sterile Injectable SKUs Investigational Medicinal Products (IMPs): Regulations, GMP, and Manufacturing Guide for 2026 Porton Advanced Secures China Drug Manufacturing License for Commercial CGT CDMO Services NueCell Bio Opens 26,300-Square-Foot Cell Therapy Development Facility AsymBio Secures 1.2397 Billion(approximately $184 million) Yuan to Expand Biologics CDMO Capacity Altasciences Expands R&D Laboratory to Integrate Formulation and Analytical Testing Piramal Pharma Solutions Launches Spray Drying Suite for Peptide Development Niagen Bioscience Selects Evotec as CRO to Advance IND-Enabling Development for NB4168 in Ataxia Telangiectasia CordenPharma Completes Acquisition of AmbioPharm to Expand Peptide CDMO Network Enzene Introduces NeX to Expand Global Biologics Manufacturing Taysha Signs Commercial Supply Agreement with Catalent for TSHA-102 Integer to Be Acquired by KKR in $5.7 Billion Deal WuXi AppTec Reports 38.9% Revenue Growth in H1 2026 Genezen Partners with Raiden Science Foundation on UBA5 Gene Therapy Manufacturing More news + insights Transcenta to Sell Hangzhou CDMO Assets to WuXi Biologics Gland Pharma Secures Manufacturing Deal Covering 55 Sterile Injectable SKUs Investigational Medicinal Products (IMPs): Regulations, GMP, and Manufacturing Guide for 2026 PODCASTS When Outsourcing Goes Wrong: How to Spot a Failing CDMO Relationship Before It Costs You a Launch Why the Least Expensive CDMO Could Cost the Most: A Procurement Leader’s Guide to Total Cost of Ownership SPOTLIGHT Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success UPCOMING EVENTS AI + Digital Maturity in Contract Manufacturing 2026 External Manufacturing Leaders Basel 2026 External Manufacturing Leaders Dublin 2026 CDMO Live Americas . October 20-21, Boston 2026
Niagen Bioscience Selects Evotec as CRO to Advance IND-Enabling Development for NB4168 in Ataxia Telangiectasia
Why the Least Expensive CDMO Could Cost the Most: A Procurement Leader’s Guide to Total Cost of Ownership